Ironwood Pharmaceuticals, Inc. (IRWD)
3.46
-0.11
(-3.08%)
USD |
NASDAQ |
Oct 23, 16:00
3.455
0.00 (0.00%)
After-Hours: 20:00
Ironwood Pharmaceuticals Price : 3.46 for Oct. 23, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 23, 2026 | 3.52 | 3.536 | 3.38 | 3.46 | 1.261M |
| Oct 22, 2026 | 3.50 | 3.605 | 3.49 | 3.57 | 1.041M |
| Oct 21, 2026 | 3.68 | 3.69 | 3.521 | 3.55 | 1.519M |
| Oct 20, 2026 | 3.57 | 3.71 | 3.525 | 3.63 | 1.641M |
| Oct 19, 2026 | 3.53 | 3.59 | 3.475 | 3.56 | 1.679M |
| Oct 16, 2026 | 3.73 | 3.73 | 3.48 | 3.50 | 2.531M |
| Oct 15, 2026 | 3.63 | 3.87 | 3.63 | 3.77 | 2.045M |
| Oct 14, 2026 | 3.55 | 3.63 | 3.51 | 3.60 | 1.223M |
| Oct 13, 2026 | 3.74 | 3.78 | 3.545 | 3.59 | 2.106M |
| Oct 12, 2026 | 3.82 | 3.85 | 3.74 | 3.76 | 1.036M |
| Oct 09, 2026 | 3.88 | 3.95 | 3.81 | 3.82 | 1.722M |
| Oct 08, 2026 | 3.70 | 3.965 | 3.67 | 3.87 | 2.404M |
| Oct 07, 2026 | 3.58 | 3.87 | 3.54 | 3.75 | 2.051M |
| Oct 06, 2026 | 3.64 | 3.679 | 3.595 | 3.63 | 1.870M |
| Oct 05, 2026 | 3.59 | 3.67 | 3.55 | 3.65 | 2.227M |
| Oct 02, 2026 | 3.74 | 3.796 | 3.58 | 3.64 | 2.701M |
| Oct 01, 2026 | 3.95 | 3.97 | 3.735 | 3.76 | 2.643M |
| Sep 30, 2026 | 4.16 | 4.17 | 3.96 | 3.97 | 1.662M |
| Sep 29, 2026 | 4.12 | 4.17 | 4.08 | 4.16 | 1.233M |
| Sep 28, 2026 | 4.09 | 4.17 | 4.04 | 4.12 | 1.963M |
| Sep 25, 2026 | 4.22 | 4.25 | 4.10 | 4.13 | 1.320M |
| Sep 24, 2026 | 4.23 | 4.260 | 4.05 | 4.19 | 1.746M |
| Sep 23, 2026 | 4.50 | 4.536 | 4.25 | 4.27 | 1.658M |
| Sep 22, 2026 | 4.46 | 4.59 | 4.395 | 4.525 | 3.428M |
| Sep 21, 2026 | 4.39 | 4.595 | 4.30 | 4.41 | 2.415M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| AbbVie, Inc. | 285.64 |
| Xencor, Inc. | 25.18 |
| Viking Therapeutics, Inc. | 24.40 |
| IDEAYA Biosciences, Inc. | 34.71 |
| BioMarin Pharmaceutical, Inc. | 55.95 |
Price Related Metrics
| PE Ratio | 4.512 |
| PS Ratio | 1.498 |
| Price to Free Cash Flow | 3.142 |
| Earnings Yield | 22.16% |
| Market Cap | 571.73M |
| Operating PE Ratio | 2.470 |
| Normalized PE Ratio | 4.469 |